New Trends in Biomarkers and Diseases Research: An Overview


by

Juan Antonio Vílchez, María Dolores Albaladejo-Otón

DOI: 10.2174/97816810849541170101
eISBN: 978-1-68108-495-4, 2017
ISBN: 978-1-68108-496-1





Biomarkers are any measurable biochemical characteristics of an organism that reflect a particular physiological state. Biomarkers can...[view complete introduction]

Metabolic Syndrome and Inflammation: Interrelated Aspects and Biomarkers Involved

- Pp. 23-56 (34)

Jose Pedregosa-Díaz, María Henar García-Lagunar and María Dolores Albaladejo-Otón

Abstract

Metabolic syndrome is considered a cluster of cardiovascular risk factors that are presented both in a single individual. They include insulin resistance, type 2 diabetes mellitus, dyslipidemia, hypertension and central obesity. Metabolic syndrome is related to systemic alterations that involve several tissues, such as liver, muscle, adipose tissue, stomach and immune system, varying the production of many biomolecules. Due to the main outcome of this clinical state being cardiovascular disease, metabolic syndrome has become a significant clinical priority.This global disturbance can be first detected and monitored later by several plasmatic biomarkers. This chapter intends to review a battery of avant-garde biomarkers related to metabolic syndrome.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science